Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2025)
Stoke Therapeutics (STOK) has 4 years of Asset Utilization Ratio data on record, last reported at 0.55 in Q3 2025.
- For Q3 2025, Asset Utilization Ratio rose 891.2% year-over-year to 0.55; the TTM value through Sep 2025 reached 0.55, up 891.2%, while the annual FY2024 figure was 0.15, 303.44% up from the prior year.
- Asset Utilization Ratio reached 0.55 in Q3 2025 per STOK's latest filing, up from 0.51 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.56 in Q1 2025 and bottomed at 0.05 in Q4 2022.
- Average Asset Utilization Ratio over 4 years is 0.18, with a median of 0.06 recorded in 2023.
- Peak YoY movement for Asset Utilization Ratio: fell 2.6% in 2024, then surged 891.2% in 2025.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.05 in 2022, then grew by 26.27% to 0.06 in 2023, then skyrocketed by 120.5% to 0.13 in 2024, then soared by 326.65% to 0.55 in 2025.
- Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.55 in Q3 2025, 0.51 in Q2 2025, and 0.56 in Q1 2025.